![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
B Nare, RK Prichard and E Georges
Institute of Parasitology, McGill University, Ste. Anne de Bellevue, Canada.
The overexpression of P-glycoprotein is currently believed to be responsible for the enhanced efflux or decreased influx of cytotoxic drugs across the cell membrane in drug-resistant cells. P-glycoprotein has been proposed to mediate the efflux of a large number of structurally and functionally unrelated drugs. Although it has been suggested that P-glycoprotein binds directly to many lipophilic cations, it remains unclear whether one or more sites in P-glycoprotein mediate its broad substrate specificity. In this report, a photoactive derivative of rhodamine 123 (Rh123) [125I-azidosalicylic acid (ASA)- Rh123] was synthesized and used in a photoaffinity labeling assay to demonstrate, for the first time, direct and specific binding to P- glycoprotein. The photoaffinity labeling of P-glycoprotein by ASA-Rh123 was specifically inhibited in the presence of vinblastine and verapamil but not in the presence of colchicine. Surprisingly, ASA-Rh123 photoaffinity labeled a 6-kDa V8 peptide in P-glycoprotein that was previously shown to be photoaffinity labeled by another multidrug resistance-associated drug, [125I]iodoarylazidoprazosin. Photoaffinity labeling of mitochondria from drug-sensitive or -resistant cells with 125I-ASA-Rh123 did not reveal significant differences in the mitochondrial proteins from sensitive or resistant cells. Interestingly, however, 125I-ASA-Rh123 did photolabel a 66-kDa protein in mitochondria that was not detected in plasma membrane preparations with this assay. Taken together, our results demonstrate for the first time that Rh123 binds specifically to P-glycoprotein and that its binding site may be shared by other multidrug resistance-associated drugs.
This article has been cited by other articles:
|
|
 |
|
  C. Gauthier, S. Weber, A.-M. Alarco, O. Alqawi, R. Daoud, E. Georges, and M. Raymond Functional Similarities and Differences between Candida albicans Cdr1p and Cdr2p Transporters Antimicrob. Agents Chemother., May 1, 2003; 47(5): 1543 - 1554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-M. Qian, W. Qiu, M. Gao, C. J. Westlake, S. P. C. Cole, and R. G. Deeley Characterization of Binding of Leukotriene C4 by Human Multidrug Resistance Protein 1. EVIDENCE OF DIFFERENTIAL INTERACTIONS WITH NH2- AND COOH-PROXIMAL HALVES OF THE PROTEIN J. Biol. Chem., October 12, 2001; 276(42): 38636 - 38644. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Jacob, M. Aguado, D. Fallik, and F. Praz The Role of the DNA Mismatch Repair System in the Cytotoxicity of the Topoisomerase Inhibitors Camptothecin and Etoposide to Human Colorectal Cancer Cells Cancer Res., September 1, 2001; 61(17): 6555 - 6562. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Drenou, T. Lamy, L. Amiot, O. Fardel, S. Caulet-Maugendre, M. Sasportes, J. Diebold, P.-Y. Le Prise, and R. Fauchet CD3-CD56+ Non-Hodgkin's Lymphomas With an Aggressive Behavior Related to Multidrug Resistance Blood, April 15, 1997; 89(8): 2966 - 2974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Nare, G. Lubega, R. K. Prichard, and E. Georges p-Azidosalicyl-5-amino-6-phenoxybenzimidazole Photolabels the N-terminal 63-103 Amino Acids of Haemonchus contortus beta-Tubulin 1 J. Biol. Chem., April 12, 1996; 271(15): 8575 - 8581. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
